share_log

Piper Sandler Initiates Coverage On IO Biotech With Overweight Rating, Announces Price Target of $10

Benzinga ·  Sep 28, 2023 07:17

Piper Sandler analyst Christopher Raymond initiates coverage on IO Biotech (NASDAQ:IOBT) with a Overweight rating and announces Price Target of $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment